- Home
- CHRS vs NPV Comparison
CHRS vs NPV Comparison
Compare CHRS & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHRS | NPV |
|---|---|---|
| Founded | 2010 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.0M | 207.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHRS | NPV |
|---|---|---|
| Price | $1.40 | $11.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.02 | N/A |
| AVG Volume (30 Days) | ★ 859.2K | 38.9K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $277,728,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $67.31 | N/A |
| P/E Ratio | $1.00 | ★ N/A |
| Revenue Growth | ★ 152.07 | N/A |
| 52 Week Low | $0.71 | $8.92 |
| 52 Week High | $1.89 | $11.55 |
Technical Indicators
Market Signals| Indicator | CHRS | NPV |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 38.17 |
| Support Level | $1.27 | $11.03 |
| Resistance Level | $1.43 | $11.30 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 71.05 | 22.56 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.